Showing 9991-10000 of 15433 results for "reverse type I diabetes".
- Unraveling the Neural Tapestry: How Epilepsy Alters Word Memoryhttps://reachmd.com/news/unraveling-the-neural-tapestry-how-epilepsy-alters-word-memory/2471772/Leading-edge neuroimaging has unearthed vital knowledge about how epileptic activity impacts the brain's word memory regions, thus altering key cognitive functions. New breakthroughs have isolated brain regions critical to word memory. By bridgi
- Breakthrough in Advanced Melanoma: Novel Oral Therapy Targets Metastasishttps://reachmd.com/news/breakthrough-in-advanced-melanoma-novel-oral-therapy-targets-metastasis/2471768/An encouraging new combination drug therapy exhibits potential in treating advanced melanoma and inhibiting its spread to the brain. This innovative dual-action strategy could substantially enhance treatment outcomes for one of the most formidable forms of skin cancer.
- Exploring the Genetic Link Between Lipids, Lipid-Lowering Therapies, and Breast Cancer Riskhttps://reachmd.com/news/exploring-the-genetic-link-between-lipids-lipid-lowering-therapies-and-breast-cancer-risk/2471726/Emerging evidence points to alterations in lipid metabolism—indicated by overexpression of genes such as SREBP1, ACLY, and ACACA—as directly linked to breast cancer development. This discovery underscores the significance of monitoring
- Real-World Effectiveness of Etanercept Biosimilar in Managing Rheumatoid Arthritishttps://reachmd.com/news/real-world-effectiveness-of-etanercept-biosimilar-in-managing-rheumatoid-arthritis/2471686/Enhancing RA Management Through Integrated Clinical and Ultrasound Metrics This article presents a comprehensive analysis of the real-world impact of etanercept biosimilar in rheumatoid arthritis, emphasizing the advantages of integrating clinical assessments with
- Why Chronic Pain May Differ Between Women and Menhttps://reachmd.com/news/why-chronic-pain-may-differ-between-women-and-men/2471758/New Research Identifies Sex-Specific Mechanisms Behind Chronic Pain A new study from the University of Calgary provides insight into why women are more likely to experience ch
- Subcutaneous Drug Delivery in Oncology: A Paradigm Shift in Cancer Carehttps://reachmd.com/news/subcutaneous-drug-delivery-in-oncology-a-paradigm-shift-in-cancer-care/2471699/Transforming Cancer Treatment Through Subcutaneous Innovations Recent clinical trial data and evolving treatment protocols are reshaping cancer care by demonstrating the benefits of subcutaneous (SC) drug delivery over traditional intravenous
- Lipid Metabolites Linked to Atopic Dermatitis Riskhttps://reachmd.com/news/lipid-metabolites-linked-to-atopic-dermatitis-risk/2471714/A two-sample Mendelian randomization (TSMR) study has identified 13 lipid-related metabolite traits that influence the risk of developing atopic dermatitis (AD). Researchers examined genome-wide association study (GWAS) datase
- Evaluating LiverMultiScan: A Promising Diagnostic Tool for MASLDhttps://reachmd.com/news/evaluating-livermultiscan-a-promising-diagnostic-tool-for-masld/2471705/A recent trial examined LiverMultiScan, a non-invasive diagnostic tool, confirming its substantial capability in pinpointing liver fibrosis linked to MASLD. By refining the diagnostic process and lessening the dependency on invasive methods, this groundbreaking tec
- Revolutionizing Parkinsonian Disorder Diagnosis: The Role of AI-driven MRI Analysishttps://reachmd.com/news/revolutionizing-parkinsonian-disorder-diagnosis-the-role-of-ai-driven-mri-analysis/2471752/Recent advancements in AI-driven MRI analysis, particularly through the Automated Imaging Differentiation for Parkinsonism (AIDP) technique, are transforming the diagnostic landscape for Parkinson’s disease and atypical parkinsonian disorders, as demonstrated by a compellin
- Harnessing AI to Uncover Novel Therapeutic Targets in Rare Salivary Gland Cancerhttps://reachmd.com/news/harnessing-ai-to-uncover-novel-therapeutic-targets-in-rare-salivary-gland-cancer/2471749/Recent advancements in artificial intelligence are transforming medical research, offering renewed hope for patients with adenoid cystic carcinoma—an uncommon and aggressive salivary gland cancer with limited treatment options. Utilizing AI-driv
